CCL3 and neoplasm: SHP2 activation is known to influence the tumor microenvironment; an activating mutation in PTPN11 in mesenchymal stem cells exhibited excessive production of CCL3, which recruited monocytes leading to aggravated childhood myeloproliferative neoplasm70.